Wedmont Private Capital’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.01M Sell
41,785
-9,950
-19% -$260K 0.03% 349
2026
Q1
$1.42M Buy
51,735
+14,744
+40% +$393K 0.05% 235
2025
Q4
$935K Buy
36,991
+5,825
+19% +$147K 0.03% 306
2025
Q3
$819K Buy
31,166
+6,563
+27% +$162K 0.03% 323
2025
Q2
$629K Buy
24,603
+1,354
+6% +$31.6K 0.03% 367
2025
Q1
$509K Sell
23,249
-7,585
-25% -$198K 0.03% 378
2024
Q4
$824K Sell
30,834
-6,639
-18% -$180K 0.04% 266
2024
Q3
$1.09M Buy
37,473
+1,994
+6% +$58.2K 0.06% 192
2024
Q2
$1.03M Buy
35,479
+5,435
+18% +$150K 0.06% 193
2024
Q1
$805K Sell
30,044
-3,402
-10% -$94.4K 0.06% 221
2023
Q4
$989K Buy
33,446
+202
+0.6% +$6.11K 0.08% 165
2023
Q3
$1.1M Buy
33,244
+9,837
+42% +$348K 0.11% 113
2023
Q2
$850K Sell
23,407
-5,089
-18% -$198K 0.09% 150
2023
Q1
$1.19M Sell
28,496
-8,438
-23% -$364K 0.16% 92
2022
Q4
$1.88M Buy
36,934
+11,575
+46% +$555K 0.28% 60
2022
Q3
$1.11M Sell
25,359
-1,108
-4% -$53.8K 0.22% 71
2022
Q2
$1.39M Buy
26,467
+9,491
+56% +$484K 0.3% 57
2022
Q1
$865K Buy
16,976
+3,315
+24% +$172K 0.19% 87
2021
Q4
$759K Buy
+13,661
New +$677K 0.23% 72

Other funds holding PFE

Wedmont Private Capital's PFE Position: Q2 2026 in Review

Wedmont Private Capital reduced its Pfizer (PFE) stake by 19% in Q2 2026, selling an estimated $260K and leaving 41,785 shares worth $1.01M. The position accounts for 0.03% of the portfolio, ranked #349.

Wedmont Private Capital first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.88M in Q4 2022. 1,247 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Wedmont Private Capital held 41,785 shares of Pfizer worth $1.01M as of Q2 2026.
  • Wedmont Private Capital sold 9,950 Pfizer shares in Q2 2026, an estimated $260K.
  • Pfizer made up 0.03% of Wedmont Private Capital's portfolio in Q2 2026, its #349 holding.
  • Wedmont Private Capital first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
  • Wedmont Private Capital's Pfizer position peaked at $1.88M in Q4 2022.
  • 1,247 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Wedmont Private Capital's 13F filing for Q2 2026, filed 13 Jul 2026.